PRESS-NEWS.org - Press Release Distribution
FREE PRESS RELEASES DISTRIBUTION

New Hepatitis C Clinical Trial Now Enrolling at Avail Clinical Research Near Orlando, Florida; Accepting M/F Patients with Hep C Age 18-65

Avail is conducting a 12-week, Phase 2, Randomized Study to Evaluate the Safety and Efficacy of a new drug in Subjects with Chronic Hepatitis C Infection.

2013-06-12
DELAND, FL, June 12, 2013 (Press-News.org) *To see if you qualify for this Hepatitis C Clinical Trial, visit Avail Clinical Research on the web or contact us directly at (386) 785-2404.

BACKGROUND

The Hepatitis C virus (HCV) infection is a global public health problem. The global prevalence of hepatitis C infection is estimated to average 3% resulting in approximately 170 million HCV-infected persons worldwide. Most of those infected develop persistent, chronic infection. An estimated 20-50% of patients with chronic HCV infection are at risk for developing such long-term complications as cirrhosis and hepatocellular carcinoma (HCC).

PRIMARY OBJECTIVES

The primary objectives of this Hep C Clinical Study are to evaluate the:

Safety and tolerability of a new Hep C drug and simeprevir when given in combination with RBV for up to 12 weeks.

Efficacy of a new Hep C drug and simeprevir when given in combination with RBV for up to 12 weeks.

SECONDARY OBJECTIVES

The secondary objectives are to evaluate the:

1. Pharmacokinetics (PK) of a new Hepatitic C drug and simeprevir when given in combination with RBV.

2. PK/Pharmacodynamics (PK/PD) of a new Hepatitic C drug and simeprevir when given in combination with RBV.

3. Emergence of resistance mutations over 12-weeks of combination treatment of a new Hepatitic C drug, simeprevir and RBV and in the post-treatment follow-up period.

INCLUSION CRITERIA

1. 18 (or the legal age of consent per local regulations, if greater than 18 years) to 65 years of age, inclusive.

2. Female subjects of both childbearing potential and non-childbearing potential may be included, unless the local regulatory authority requires that only females of non-childbearing potential be included. Non-childbearing potential is defined as one of the following:

Postmenopausal, defined as amenorrheic for at least 2 years and serum follicle stimulating hormone (FSH) level consistent with postmenopausal status at Screening, OR

A documented hysterectomy, bilateral oophorectomy or bilateral tubal ligation at least 6 months prior to study initiation.
3. All female subjects must have a negative serum beta-human chorionic gonadotropin (β-HCG) at Screening and a negative urine pregnancy test prior to the first dose of study medication on Day 1.

4. Women of childbearing potential and men must have agreed to use an acceptable double method of birth control (one of which must be a barrier method) from Screening through at least 6 months after the last dose of study drugs.

5. Male subjects must have agreed not to donate sperm from the first dose through at least 6 months after the last dose of study drugs.

6. QTcF interval ≤ _450 ms at Screening and prior to dosing on Day 1.

7. Documented clinical history compatible with chronic hepatitis C, including any one of the following:

a) anti- HCV antibody positive at least 6 months prior to Screening or dosing, OR

b) HCV RNA present in plasma by a sensitive and specific assay at least 6 months prior to Screening or dosing, OR

c) HCV genotype at least 6 months prior to Screening or dosing, OR

d) histologic evidence of chronic hepatitis C infection.

8. Must not have received prior antiviral treatment for HCV infection.

9. Plasma HCV RNA positive at Screening with minimal viral load according to genotype:

a) Genotype 1b HCV RNA ≠5 log10 IU/mL

b) Genotype 4 HCV RNA ≠_4 log10 IU/mL

10. HCV genotype 1b or 4 by HCV genotyping performed at Screening (Note: mixed subtypes are not acceptable).

11. Documented absence of cirrhosis within 36 months of Screening or dosing (histology or non-invasive equivalent, according to local standard of care).

12. Subject is, in the opinion of the investigator, willing and able to comply with the protocol and all other study requirements.

13. Subject has provided written informed consent to participate in the study.

BENEFITS OF PARTICIPATION

Receive medical care at No Cost
Health Insurance is not required
Receive Compensation for time & travel
Help Advance medical research

*Avail Clinical Research conducts Clinical Research Trials in Florida. For more information about participating in a Hep C Clinical Study, please visit our website or contact us directly at (386) 785-2404.


ELSE PRESS RELEASES FROM THIS DATE:

Parties2Order Launches New Retail Website

2013-06-12
Parties2Order, of New Britain, Pa, has launched their new website, Parties2Order.com, providing customers with an online retail store of their high-end, unique party supplies. Parties2Order was created from Bucks Mont Party Rentals, a 25-year old party rental company in Bucks County, Pa started by Dave and Sylvia Fermier. Their granddaughter, Brittney Horvath came on board to launch the online party supply store, Parties2Order to give their customers the convenience of shopping online with the company. Parties2Order.com plans to provide each and every customer with ...

Restaurant Expert Witness Launches New Company Logo Reflecting the Uniqueness of Its Services

2013-06-12
The CEO of Restaurant Expert Witness, Howard Cannon, announces the launching of a new company logo as unique as the services it provides. "What's in a name," asks Shakespeare? Well, in this case, everything. "We are excited about a new and fresh cutting edge look to the Restaurant Expert Witness logo," says Mr. Cannon. "I wanted more of a legal icon to use for new content that we will be releasing in the next couple of months." Cannon also states that July 2013 will mark the 26th year anniversary for his company. It doesn't take much ...

Crown & Caliber Expands Website to Accommodate International Customers

2013-06-12
Crown & Caliber [http://www.crownandcaliber.com/], the leading purchaser of pre-owned luxury watches, has launched a new International Section [http://www.crownandcaliber.com/selling-internationally/] to its website in order to better serve its international customers. With the launch of this new section, non-American customers can now enjoy the same ease, security and reward of selling their watches to Crown & Caliber as US-based customers do. Because of the company's large base of customers across the globe, Crown & Caliber wants to make it easier and more ...

Morton'S Enhances Wines By The Glass Offering In Two Locations With Napa Technology Winestation 3.0

2013-06-12
Preservation and dispensing systems help operators manage the quality of wines-by-the-glass programs, which translates to customer satisfaction and repeat business. The WineStation's 60-day preservation capabilities and temperature-controlled environment can be installed in under an hour and eliminates costly, often disruptive, renovation. The Napa Technology WineStation supports the highest level of profitability and customer satisfaction from the first pour to the very last. Napa Technology's WineStation makes wine more accessible to consumers and to provides a tool ...

MTM Cincinnati Model Taelor Howie with Funny Face Today Agency in New York

2013-06-12
Congratulations to MTM Model and Actress Taelor Howie for receiving the opportunity to work with the Funny Face Today Agency in New York. Taelor will spend a month in New York auditioning for national commercials and print work. Taelor has been represented by MTM Cincinnati since 2011. Her most recent booking was walking the runway for the American Girl Doll Fashion show in April. Taelor has also been a cover model three times, one for Kentucky Kids Magazine and twice for the Lexington Family Magazine. She is very involved in her school's theatre productions as well. ...

Evan Guthrie Law Firm Speaks At Higher Learning Academy At Fort Dorchester High School In Charleston, SC

2013-06-12
Evan Guthrie of the Evan Guthrie Law Firm in Charleston, South Carolina spoke at the Dorchester County District Two Higher Learning Academy at Fort Dorchester High School in North Charleston, SC on Saturday March 9th 2013. The event was the second in the series of Higher Learning Academies for the 2012 - 2013 school year. The event included students from all of the high schools in Dorchester District Two including Ashley Ridge, Fort Dorchester, and Summerville. The Academy includes several Saturday programs that students can attend to learn more how to get ready go to college ...

Renaissance House Retreat for Writers & Artists Kicks-Off 12th Anniversary in Martha's Vineyard

2013-06-12
Renaissance House: A Retreat for Writers and Other Artists kicks-off its 12th anniversary retreat in historic Oak Bluffs, Martha's Vineyard in June. Renaissance House, which is held from June through October, provides writers and other artists with a subsidized retreat away from life's responsibilities and the space in which to create new works of art. Renaissance House is one of the few retreats designed for issue-oriented writers, writers of color and writers of social justice. Sponsored by the Helene Johnson and Dorothy West Foundation, Renaissance House was named ...

Calvert Labs and EyeCRO Announce Strategic Partnership in Ocular Research

2013-06-12
Calvert Labs and EyeCRO, two leading providers in early-stage ocular drug research and development, announced today that they have entered into a strategic partnership to expedite preclinical drug development activities. "This partnership will facilitate a seamless transition from the discovery and non-GLP stage of drug development to the performance of GLP IND-enabling studies," said Charles B. Spainhour, V.M.D, Ph.D., President and Chief Scientific Officer of Calvert Labs. The expert team at EyeCRO has 55 plus years of combined experience utilizing ophthalmic ...

Specialist Recruitment Agency helps Engineering Firms Find The Best Talent Before Their Competitors

2013-06-12
Hanic International has been established to ensure that firms looking to hire their next recruit not only have access to the best talent pool, but that they also get a good return on investment , something which founder, Ian Hopwood, believes is essential in the current climate. Mr Hopwood said: "In the current economic climate, firms looking to recruit their next generation of talent need to know that the money they invest will yield them only the very best employees with the skills and knowledge to match. "It's tough, companies need staff to keep the business ...

Booming Children's Swimwear Market Brings a Flood of New Swimwear Lines to SwimShow

2013-06-12
Just as kids continue to grow like weeds, so does the market for children's swimwear. In just one year at the annual Swimwear Association of Florida's SwimShow, the category reported nearly 25 percent growth, and more swimwear lines for kids will be added for this year's show, July 20-23 at the Miami Beach Convention Center. This year's 31st annual global trade show will welcome more than 8,500 attendees and 2,500 brands from 60 countries. Hot swimwear lines for kids will include Cache, Kiwi, Cabana Life, Stella Cove, Floatimini, Snapper Rock, Lemons & Limes, Planet ...

LAST 30 PRESS RELEASES:

Scientists model 'true prevalence' of COVID-19 throughout pandemic

New breakthrough to help immune systems in the fight against cancer

Through the thin-film glass, researchers spot a new liquid phase

Administering opioids to pregnant mice alters behavior and gene expression in offspring

Brain's 'memory center' needed to recognize image sequences but not single sights

Safety of second dose of mRNA COVID-19 vaccines after first-dose allergic reactions

Changes in disparities in access to care, health after Medicare eligibility

Use of high-risk medications among lonely older adults

65+ and lonely? Don't talk to your doctor about another prescription

Exosome formulation developed to deliver antibodies for choroidal neovascularization therapy

Second COVID-19 mRNA vaccine dose found safe following allergic reactions to first dose

Plant root-associated bacteria preferentially colonize their native host-plant roots

Rare inherited variants in previously unsuspected genes may confer significant risk for autism

International experts call for a unified public health response to NAFLD and NASH epidemic

International collaboration of scientists rewrite the rulebook of flowering plant genetics

Improving air quality reduces dementia risk, multiple studies suggest

Misplaced trust: When trust in science fosters pseudoscience

Two types of blood pressure meds prevent heart events equally, but side effects differ

New statement provides path to include ethnicity, ancestry, race in genomic research

Among effective antihypertensive drugs, less popular choice is slightly safer

Juicy past of favorite Okinawan fruit revealed

Anticipate a resurgence of respiratory viruses in young children

Anxiety, depression, burnout rising as college students prepare to return to campus

Goal-setting and positive parent-child relationships reduce risk of youth vaping

New research identifies cancer types with little survival improvements in adolescents and young adul

Oncotarget: Replication-stress sensitivity in breast cancer cells

Oncotarget: TERT and its binding protein: overexpression of GABPA/B in gliomas

Development of a novel technology to check body temperature with smartphone camera

The mechanics of puncture finally explained

Extreme heat, dry summers main cause of tree death in Colorado's subalpine forests

[Press-News.org] New Hepatitis C Clinical Trial Now Enrolling at Avail Clinical Research Near Orlando, Florida; Accepting M/F Patients with Hep C Age 18-65
Avail is conducting a 12-week, Phase 2, Randomized Study to Evaluate the Safety and Efficacy of a new drug in Subjects with Chronic Hepatitis C Infection.